Article
Treating a Pandemic Respiratory Disease with a Mutagen is a Doomsday Scenario
2022-01-21
Abstract excerpt
Merck's Molnupiravir is a global catastrophic risk. Its broad use as a treatment for COVID-19 will create dangerous variants of SARS-COV-2. It is already in use in some countries. Molnupiravir ("MOLN"), a presumed anti-COVID19 drug, acts by significantly increasing the RNA error rate in the coronavirus replication. That exponentially increases the probability of many mutations in a single copy. Copies containing a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- db51c6ec-071a-55ad-bd46-e3ea0c6a1ecb
- DOI
- 10.22541/au.163854323.34557301/v2
